WHO ICTRP trial
A clinical study of chimeric antigen receptor T-cell immunotherapy in the…
ChiCTR-OIC-16008291 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-OIC-16008291 |
|---|---|
| Public title | A clinical study of chimeric antigen receptor T-cell immunotherapy in the treatment of CD19+ B-cell hematologic malignancies |
| Scientific title | A clinical study of chimeric antigen receptor T-cell immunotherapy in the treatment of CD19+ B-cell hematologic malignancies |
| Primary sponsor | The Affiliated Hospital of Xuzhou Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | B-cell hematologic malignancies |
| Interventions | 1:CAR-T cells |
| Registration date | Apr 16, 2016 |
| Target size | 1:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: